awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36058025-1EE13901-2D80-4AE2-9282-EFA7A7AFD3C7
Q36058025-1EE13901-2D80-4AE2-9282-EFA7A7AFD3C7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36058025-1EE13901-2D80-4AE2-9282-EFA7A7AFD3C7
Trelagliptin (SYR-472, Zafatek), Novel Once-Weekly Treatment for Type 2 Diabetes, Inhibits Dipeptidyl Peptidase-4 (DPP-4) via a Non-Covalent Mechanism.
P2860
Q36058025-1EE13901-2D80-4AE2-9282-EFA7A7AFD3C7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36058025-1EE13901-2D80-4AE2-9282-EFA7A7AFD3C7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9b960f737ddf7a34ca85645760a3114132e5b8af
P2860
(2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: a potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.